Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125270341 | 12527034 | 1 | I | 20160109 | 20160112 | 20160705 | 20160705 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN003386 | GLAXOSMITHKLINE | 75.00 | YR | F | Y | 55.00000 | KG | 20160705 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125270341 | 12527034 | 1 | PS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | UNK | 15000 | MG | Y | 20487 | TABLET | ||||||
| 125270341 | 12527034 | 2 | SS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, 1D | 15000 | MG | Y | 20487 | 500 | MG | TABLET | QD | |||
| 125270341 | 12527034 | 3 | SS | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 1000 MG, TID | 15000 | MG | Y | 20487 | 1000 | MG | TABLET | TID | |||
| 125270341 | 12527034 | 4 | C | TALION (JAPAN) | BEPOTASTINE | 1 | 0 | ||||||||||||
| 125270341 | 12527034 | 5 | C | ERYTHROCIN | ERYTHROMYCIN LACTOBIONATE | 1 | UNK | 0 | |||||||||||
| 125270341 | 12527034 | 6 | C | UNKNOWN DRUG | UNSPECIFIED INGREDIENT | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125270341 | 12527034 | 1 | Benign familial pemphigus |
| 125270341 | 12527034 | 2 | Genital herpes |
| 125270341 | 12527034 | 4 | Benign familial pemphigus |
| 125270341 | 12527034 | 5 | Benign familial pemphigus |
| 125270341 | 12527034 | 6 | Benign familial pemphigus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125270341 | 12527034 | OT |
| 125270341 | 12527034 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125270341 | 12527034 | Decreased appetite | |
| 125270341 | 12527034 | Genital herpes | |
| 125270341 | 12527034 | Nausea | |
| 125270341 | 12527034 | Renal disorder | |
| 125270341 | 12527034 | Renal impairment | |
| 125270341 | 12527034 | Vulvar erosion | |
| 125270341 | 12527034 | Vulvovaginal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125270341 | 12527034 | 2 | 20160101 | 0 | ||
| 125270341 | 12527034 | 3 | 20160106 | 20160111 | 0 |